- Repligen | Inspiring advances in bioprocessing
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of its CTech™ SoloVPE ® PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers
- About Repligen
The innovative bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment
- Products - Repligen
Whether you are in fed-batch, hybrid continuous or full continuous mode, or working with therapeutic proteins, gene therapy or vaccines, you can use leading edge solutions from Repligen to streamline your processes and cut your manufacturing costs
- Careers - Repligen
At Repligen, we provide opportunities for conversation about DEI, offer DEI education resources, encourage allyship, and invest time and energy into developing diverse talent
- Leadership - Repligen
George A Scott, Jr joined Repligen in April 2024 as Vice President, Global Head of Legal In this role he leads the global legal operations for the Company and drives its strategic direction in support of Repligen’s mission
- Locations - Repligen
Locations About Repligen Leadership Careers News Room Investors Sustainability Contact Repligen Corporation Headquarters
- Repligen Corporation - Press Releases
Repligen Corporation to Present at Upcoming November Conferences Download Repligen Corporation to Present at Upcoming November Conferences in PDF format" (opens in new window)
- Repligen Store
Welcome to the Repligen e-store! Select filtration, chromatography, protein, and analytic products are available for purchase online
|